Michael J Zvolensky Selected Research

Nicotine

1/2021	Anxiety sensitivity, pain severity and co-use of cigarettes and e-cigarettes among adults with chronic pain.
9/2020	A randomized controlled trial protocol for engaging distress tolerance and working memory to aid smoking cessation in low socioeconomic status (SES) adults.
1/2020	The Effects of Cannabis Use: A Test Among Dual Electronic and Combustible Cigarette Users.
6/2019	Menthol cigarette use and pain reporting among African American adults seeking treatment for smoking cessation.
11/2018	Posttraumatic stress disorder and cigarette smoking: A systematic review.
1/2018	Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: an examination among successful quitters.
1/2018	Study of the relationship between anxiety sensitivity, smoking abstinence expectancies, nicotine withdrawal, and cigarette dependence among daily smokers.
2/2017	Panic attack history and smoking topography.
12/2016	Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: Findings from a self-guided quit attempt.
4/2016	Anxiety sensitivity class membership moderates the effects of pre-quit reduction in anxiety sensitivity on quit-day tobacco craving.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Zvolensky Research Topics

Disease

23	Pain (Aches) 02/2022 - 03/2011
21	Chronic Pain 02/2022 - 01/2016
19	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2020 - 01/2004
19	Panic Disorder (Panic Attack) 01/2020 - 01/2003
16	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 09/2015
13	Tobacco Use Disorder (Nicotine Dependence) 01/2021 - 12/2005
11	Substance-Related Disorders (Drug Abuse) 07/2021 - 03/2007
8	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2008
5	Anxiety Disorders (Anxiety Disorder) 11/2021 - 01/2003
4	Low Back Pain (Lumbago) 02/2022 - 01/2020
4	Alcoholism (Alcohol Abuse) 01/2021 - 01/2008
4	Hyperventilation 03/2012 - 12/2005
3	COVID-19 05/2021 - 01/2020
3	Asthma (Bronchial Asthma) 01/2019 - 05/2010
2	Fatigue 01/2021 - 01/2020
2	Chronic Disease (Chronic Diseases) 01/2020 - 02/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2018 - 01/2017
2	Neoplasms (Cancer) 01/2018 - 10/2016
2	Marijuana Use 12/2009 - 12/2007
1	Wounds and Injuries (Trauma) 01/2020
1	Acute Pain 06/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Infections 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Mental Disorders (Mental Disorder) 07/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 07/2015
1	Anhedonia 05/2013
1	Psychomotor Agitation (Akathisia) 05/2013
1	Personality Disorders (Personality Disorder) 06/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2011
1	Psychotic Disorders (Schizoaffective Disorder) 01/2011
1	Antisocial Personality Disorder (Antisocial Personality) 01/2011
1	Mood Disorders (Mood Disorder) 11/2010
1	Arthritis (Polyarthritis) 11/2010
1	Back Pain (Backache) 11/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2008
1	Alcohol-Related Disorders 09/2005

Drug/Important Bio-Agent (IBA)

33	Nicotine FDA Link 01/2021 - 01/2004
30	Opioid Analgesics (Opioids)IBA 02/2022 - 09/2015
16	SmokeIBA 11/2021 - 01/2003
7	Biological ProductsIBA 07/2015 - 01/2004
6	Pharmaceutical PreparationsIBA 01/2020 - 09/2005
6	Carbon DioxideIBA 07/2015 - 05/2007
4	Analgesics (Analgesic Drugs)IBA 11/2020 - 01/2019
4	Heroin (Diamorphine)IBA 01/2019 - 03/2007
3	SolutionsIBA 01/2020 - 12/2007
2	Hypnotics and Sedatives (Sedatives)IBA 07/2019 - 01/2018
2	Cocaine (Cocaine HCl)IBA 07/2019 - 01/2018
2	Hallucinogens (Psychedelics)IBA 01/2018 - 01/2007
2	APTIBA 01/2018 - 01/2017
2	antineoplaston A10 (A 10)IBA 03/2011 - 01/2010
1	Medical MarijuanaIBA 01/2020
1	Cycloserine (Seromycin)FDA Link 01/2020
1	ORALIT (ORS)IBA 01/2020
1	Menthol FDA Link 06/2019
1	ElementsIBA 02/2019
1	Opiate AlkaloidsIBA 12/2018
1	Illicit Drugs (Recreational Drugs)IBA 01/2018
1	Carbon MonoxideIBA 05/2014
1	Crack CocaineIBA 07/2008

Therapy/Procedure

7	Therapeutics 06/2021 - 01/2016
3	Pain Management 02/2022 - 01/2018
2	Analgesia 01/2022 - 01/2022
2	Nicotine Replacement Therapy 01/2019 - 01/2018
1	Drug Therapy (Chemotherapy) 10/2016